{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:37:21Z","timestamp":1761964641754,"version":"3.44.0"},"reference-count":20,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Qual Saf"],"accepted":{"date-parts":[[2015,3,15]]},"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:sec>\n                  <jats:title>Background and objective<\/jats:title>\n                  <jats:p>How patients respond to being notified of a large-scale adverse event (LSAE), such as improper sterilisation of medical equipment that exposes them to bloodborne pathogens, is not well known. The objective of this study was to determine, using administrative data, the intended and unintended consequences of patient notification following a LSAE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We examined five LSAEs where patients may have been inadvertently exposed to hepatitis C virus (HCV), HIV, and hepatitis B virus (HBV). A total of 9638 cases were identified at five Department of Veteran Affairs (VA) medical facilities between 2009 and 2012. We identified controls at the same facility prior to the exposure period and at neighbouring facilities (n=45\u2005274). Difference-in-differences models were used with Veterans Health Administration (VHA) and Medicare data to examine infectious disease testing rates and subsequent utilisation patterns.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Receipt of a LSAE notification was associated with a 73.2, 76.8 and 77.1 adjusted percentage point increase for HCV, HIV and HBV testing, respectively (all p&lt;0.001). Compared with white patients, African\u2013American patients were significantly less likely to return to VHA for follow-up testing. Patients exposed to a dental LSAE reduced their use of preventive and restorative dental care over the subsequent year, but they eventually came back to VHA for dental services 18-months post exposure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The majority of patients notified of a LSAE responded by getting tested for HCV, HIV and HBV, although there remains room for improvement. Potential exposure to a LSAE was associated with increased odds of subsequently using non-VA facilities, but the size and timing of the shift depended on the type of care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjqs-2014-003800","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T08:47:00Z","timestamp":1429174020000},"page":"295-302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Intended and unintended effects of large-scale adverse event disclosure: a controlled before-after analysis of five large-scale notifications"],"prefix":"10.1136","volume":"24","author":[{"given":"Todd H","family":"Wagner","sequence":"first","affiliation":[{"name":"Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, California, USA"},{"name":"Department of Health Research and Policy, Stanford University, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Health Research and Policy, Stanford University, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Cowgill","sequence":"additional","affiliation":[{"name":"Department of Health Research and Policy, Stanford University, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M","family":"Asch","sequence":"additional","affiliation":[{"name":"Department of Health Research and Policy, Stanford University, Stanford, California, USA"},{"name":"Division of General Internal Medicine, Stanford University, Stanford California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pon","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Health Research and Policy, Stanford University, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bokhour","sequence":"additional","affiliation":[{"name":"Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts, USA"},{"name":"Department of Health Policy and Management, Boston University School of Public Health, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Durfee","sequence":"additional","affiliation":[{"name":"Veterans Health Administration, Office of Public Health, Washington DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A","family":"Martinello","sequence":"additional","affiliation":[{"name":"Veterans Health Administration, Office of Public Health, Washington DC, USA"},{"name":"Yale School of Medicine, Departments of Internal Medicine and Pediatrics, New Haven, Conneticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Maguire","sequence":"additional","affiliation":[{"name":"Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A Rani","family":"Elwy","sequence":"additional","affiliation":[{"name":"Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts, USA"},{"name":"Department of Health Policy and Management, Boston University School of Public Health, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"2025090411463126000_24.5.295.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1303119"},{"key":"2025090411463126000_24.5.295.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7417.741"},{"key":"2025090411463126000_24.5.295.3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/JCE201324406","article-title":"Patients\u2019 experiences with disclosure of a large-scale adverse event","volume":"24","author":"Prouty","year":"2013","journal-title":"J Clin Ethics"},{"key":"2025090411463126000_24.5.295.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.1988.tb01168.x"},{"key":"2025090411463126000_24.5.295.5","unstructured":"Centers for Disease Control and Prevention. Patient Notification Toolkit. Secondary Patient Notification Toolkit June 6, 2013, 2013. http:\/\/www.cdc.gov\/injectionsafety\/pntoolkit\/index.html"},{"key":"2025090411463126000_24.5.295.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa030954"},{"key":"2025090411463126000_24.5.295.7","unstructured":"Veterans Health Administration. Disclosure of adverse events to patients. Washington DC: VHA Handbook 1004.08, 2012."},{"key":"2025090411463126000_24.5.295.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.11.1401"},{"key":"2025090411463126000_24.5.295.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0178.x"},{"key":"2025090411463126000_24.5.295.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhpr0706165"},{"key":"2025090411463126000_24.5.295.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22122"},{"key":"2025090411463126000_24.5.295.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2014.04.020"},{"key":"2025090411463126000_24.5.295.13","first-page":"680","article-title":"Racial differences in treatment preferences among lupus patients: a two-site study","volume":"32","author":"Vina","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411463126000_24.5.295.14","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2007.021295"},{"key":"2025090411463126000_24.5.295.15","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.076588"},{"key":"2025090411463126000_24.5.295.16","doi-asserted-by":"publisher","DOI":"10.1682\/JRRD.2009.08.0122"},{"key":"2025090411463126000_24.5.295.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2008.04.255"},{"key":"2025090411463126000_24.5.295.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014550"},{"key":"2025090411463126000_24.5.295.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhle1003134"},{"key":"2025090411463126000_24.5.295.20","doi-asserted-by":"publisher","DOI":"10.1086\/666345"}],"container-title":["BMJ Quality &amp; Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjqs-2014-003800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T18:46:38Z","timestamp":1757011598000},"score":1,"resource":{"primary":{"URL":"https:\/\/qualitysafety.bmj.com\/lookup\/doi\/10.1136\/bmjqs-2014-003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,4,16]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1136\/bmjqs-2014-003800"],"URL":"https:\/\/doi.org\/10.1136\/bmjqs-2014-003800","relation":{},"ISSN":["2044-5415","2044-5423"],"issn-type":[{"type":"print","value":"2044-5415"},{"type":"electronic","value":"2044-5423"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}